Company Filing History:
Years Active: 2022
Title: J Kevin Shoemaker: Innovator in Metabolomics Profiling for CNS Injuries
Introduction
J Kevin Shoemaker is a prominent inventor based in London, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the area of central nervous system (CNS) injuries. His innovative approach utilizes metabolomics to enhance the diagnosis of various CNS conditions.
Latest Patents
J Kevin Shoemaker holds a patent for a method titled "Metabolomics profiling of central nervous system injury." This patent focuses on diagnosing CNS injuries such as acquired brain injury (ABI) and acquired spinal cord injury (ASI). The method involves obtaining a biological test sample from the subject, identifying metabolites using metabolomics, and generating a subject's profile. By employing multivariate statistical analysis and machine learning, the method compares the subject's profile with predetermined profiles of CNS injuries and controls to determine the presence of a CNS injury. He has 1 patent in this area.
Career Highlights
Shoemaker is affiliated with the London Health Sciences Centre Research Inc., where he continues to advance research in metabolomics and its applications in diagnosing CNS injuries. His work is pivotal in improving diagnostic accuracy and patient outcomes in neurology.
Collaborations
Some of his notable coworkers include Douglas Dale Fraser and Robert Bartha, who contribute to the research efforts at the London Health Sciences Centre.
Conclusion
J Kevin Shoemaker's innovative work in metabolomics profiling represents a significant advancement in the diagnosis of central nervous system injuries. His contributions are essential for the future of medical diagnostics and patient care.